Grant: Engage Grants Program
University of Waterloo
$22,000.00
Process Optimization of a DNA Minivector Production System
FY 2019-20
Summary
The objective of the current project is to collaborate with a current process engineering firm, MemBio to optimize a purification process for production and purification of a high demand DNA minivector generation. The DNA minivectors are linear covalently closed (LCC) molecules known as DNA ministrings or msDNA. Safer DNA vectors with high stability, efficacy and efficient purification are in high demand in the gene/cell therapy industry as a genetic vector for delivery of genetic cargo. Successful completion of this project will generate proprietary processing intellectual property for physically and biochemically optimizing msDNA production and allow them to get it ready for pilot-scale testing. The success of the project will also help strengthen Canadian bio-economy by developing a manufacturing process that can be implemented nationally, and abroad. To date, separation of LCC DNA from other DNA species, both by size and topology has yet to be achieved beyond analytical levels of purification. An efficient and scaled-up approach to generation of mg scale of msDNA and other similar LCC DNA products is needed to drive new developments in genetic medicine. This proposal seeks to implement biochemical, genetic and physical strategies to purify msDNA through the most cost-effective approaches available and generate novel capabilities for MemBio in msDNA and other minivector DNA production.
Program
Engage Grants Program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
538019-2019
Name nom
Slavcev, Roderick
Department département
Pharmacy, School of
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2019
Award amount
22000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Process Optimization of a DNA Minivector Production System
Keyword
NSERC
Application summary
The objective of the current project is to collaborate with a current process engineering firm, MemBio to optimize a purification process for production and purification of a high demand DNA minivector generation. The DNA minivectors are linear covalently closed (LCC) molecules known as DNA ministrings or msDNA. Safer DNA vectors with high stability, efficacy and efficient purification are in high demand in the gene/cell therapy industry as a genetic vector for delivery of genetic cargo. Successful completion of this project will generate proprietary processing intellectual property for physically and biochemically optimizing msDNA production and allow them to get it ready for pilot-scale testing. The success of the project will also help strengthen Canadian bio-economy by developing a manufacturing process that can be implemented nationally, and abroad. To date, separation of LCC DNA from other DNA species, both by size and topology has yet to be achieved beyond analytical levels of purification. An efficient and scaled-up approach to generation of mg scale of msDNA and other similar LCC DNA products is needed to drive new developments in genetic medicine. This proposal seeks to implement biochemical, genetic and physical strategies to purify msDNA through the most cost-effective approaches available and generate novel capabilities for MemBio in msDNA and other minivector DNA production.